Enveric Biosciences Ownership 2024 | Who Owns Enveric Biosciences Now?


OverviewRevenueFinancialsChart

Institutional Ownership

21.05%

Insider Ownership

3.40%

Retail Ownership

75.56%

Institutional Holders

16.00

Enveric Biosciences Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ADVISORSHARES INVESTMENTS LLC11.06%0.04%238,83397,00068.39%238,833Mar 31, 2024
HRT FINANCIAL LP2.92%0.00%63,02663,026100.00%63,000Mar 31, 2024
CITADEL ADVISORS LLC1.86%-40,10440,104100.00%40,104Mar 31, 2024
BLACKROCK INC.1.37%-29,578--29,578Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.85%-18,24718,247100.00%18,247Mar 31, 2024
VANGUARD GROUP INC0.84%-18,198--18,198Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.71%-15,39715,397100.00%15,397Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC0.61%-13,118--13,118Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.57%0.00%12,277-397-3.13%12,277Mar 31, 2024
UBS GROUP AG0.23%-4,9834,97349730.00%4,983Mar 31, 2024
GROUP ONE TRADING, L.P.0.01%-273--273Mar 31, 2024
ADVISOR GROUP HOLDINGS, INC.0.01%-150--150,000Mar 31, 2024
BANK OF AMERICA CORP /DE/0.00%-100--100,000Mar 31, 2024
NATIONAL BANK OF CANADA /FI/0.00%-70--63Mar 31, 2024
WELLS FARGO & COMPANY/MN0.00%-37412.12%37,000Mar 31, 2024
MORGAN STANLEY--1--1Mar 31, 2024
ARMISTICE CAPITAL, LLC----273,000-100.00%-Mar 31, 2024
ORG PARTNERS LLC----10-100.00%-Mar 31, 2024

Enveric Biosciences's largest institutional shareholder is ADVISORSHARES INVESTMENTS LLC, holding 11.06% of the company's total share outstanding, currently valued at $238.83K. The top 10 institutional shareholders own together 21.02% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ADVISORSHARES INVESTMENTS LLC11.06%0.04%238,83397,00068.39%238,833Mar 31, 2024
HRT FINANCIAL LP2.92%0.00%63,02663,026100.00%63,000Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.57%0.00%12,277-397-3.13%12,277Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.71%-15,39715,397100.00%15,397Mar 31, 2024
CITADEL ADVISORS LLC1.86%-40,10440,104100.00%40,104Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.85%-18,24718,247100.00%18,247Mar 31, 2024
UBS GROUP AG0.23%-4,9834,97349730.00%4,983Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC0.61%-13,118--13,118Mar 31, 2024
GROUP ONE TRADING, L.P.0.01%-273--273Mar 31, 2024
BLACKROCK INC.1.37%-29,578--29,578Mar 31, 2024
VANGUARD GROUP INC0.84%-18,198--18,198Mar 31, 2024
ADVISOR GROUP HOLDINGS, INC.0.01%-150--150,000Mar 31, 2024
NATIONAL BANK OF CANADA /FI/0.00%-70--63Mar 31, 2024
BANK OF AMERICA CORP /DE/0.00%-100--100,000Mar 31, 2024
WELLS FARGO & COMPANY/MN0.00%-37412.12%37,000Mar 31, 2024
MORGAN STANLEY--1--1Mar 31, 2024
ARMISTICE CAPITAL, LLC----273,000-100.00%-Mar 31, 2024
ORG PARTNERS LLC----10-100.00%-Mar 31, 2024

The largest Enveric Biosciences shareholder by % of total assets is ADVISORSHARES INVESTMENTS LLC. The company owns 238.83K shares of Enveric Biosciences (ENVB), representing 0.04% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ADVISORSHARES INVESTMENTS LLC11.06%0.04%238,83397,00068.39%238,833Mar 31, 2024
HRT FINANCIAL LP2.92%0.00%63,02663,026100.00%63,000Mar 31, 2024
CITADEL ADVISORS LLC1.86%-40,10440,104100.00%40,104Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.85%-18,24718,247100.00%18,247Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.71%-15,39715,397100.00%15,397Mar 31, 2024
UBS GROUP AG0.23%-4,9834,97349730.00%4,983Mar 31, 2024
WELLS FARGO & COMPANY/MN0.00%-37412.12%37,000Mar 31, 2024
MORGAN STANLEY--1--1Mar 31, 2024
BANK OF AMERICA CORP /DE/0.00%-100--100,000Mar 31, 2024
NATIONAL BANK OF CANADA /FI/0.00%-70--63Mar 31, 2024
ADVISOR GROUP HOLDINGS, INC.0.01%-150--150,000Mar 31, 2024
VANGUARD GROUP INC0.84%-18,198--18,198Mar 31, 2024
BLACKROCK INC.1.37%-29,578--29,578Mar 31, 2024
GROUP ONE TRADING, L.P.0.01%-273--273Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC0.61%-13,118--13,118Mar 31, 2024
ORG PARTNERS LLC----10-100.00%-Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.57%0.00%12,277-397-3.13%12,277Mar 31, 2024
ARMISTICE CAPITAL, LLC----273,000-100.00%-Mar 31, 2024

As of Mar 31 2024, Enveric Biosciences's largest institutional buyer is ADVISORSHARES INVESTMENTS LLC. The company purchased 97.00K stocks of ENVB, valued at $238.83K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARMISTICE CAPITAL, LLC----273,000-100.00%-Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.57%0.00%12,277-397-3.13%12,277Mar 31, 2024
ORG PARTNERS LLC----10-100.00%-Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC0.61%-13,118--13,118Mar 31, 2024
GROUP ONE TRADING, L.P.0.01%-273--273Mar 31, 2024
BLACKROCK INC.1.37%-29,578--29,578Mar 31, 2024
VANGUARD GROUP INC0.84%-18,198--18,198Mar 31, 2024
ADVISOR GROUP HOLDINGS, INC.0.01%-150--150,000Mar 31, 2024
NATIONAL BANK OF CANADA /FI/0.00%-70--63Mar 31, 2024
BANK OF AMERICA CORP /DE/0.00%-100--100,000Mar 31, 2024
MORGAN STANLEY--1--1Mar 31, 2024
WELLS FARGO & COMPANY/MN0.00%-37412.12%37,000Mar 31, 2024
UBS GROUP AG0.23%-4,9834,97349730.00%4,983Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.71%-15,39715,397100.00%15,397Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.85%-18,24718,247100.00%18,247Mar 31, 2024
CITADEL ADVISORS LLC1.86%-40,10440,104100.00%40,104Mar 31, 2024
HRT FINANCIAL LP2.92%0.00%63,02663,026100.00%63,000Mar 31, 2024
ADVISORSHARES INVESTMENTS LLC11.06%0.04%238,83397,00068.39%238,833Mar 31, 2024

As of Mar 31 2024, Enveric Biosciences's biggest institutional seller is ARMISTICE CAPITAL, LLC. The company sold -0.27M shares of ENVB, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
HRT FINANCIAL LP2.92%0.00%63,02663,026100.00%63,000Mar 31, 2024
CITADEL ADVISORS LLC1.86%-40,10440,104100.00%40,104Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.85%-18,24718,247100.00%18,247Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.71%-15,39715,397100.00%15,397Mar 31, 2024

Enveric Biosciences's largest new institutional shareholder by number of shares is HRT FINANCIAL LP, purchased 63.03K shares, valued at $63.00K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARMISTICE CAPITAL, LLC----273,000-100.00%-Mar 31, 2024
ORG PARTNERS LLC----10-100.00%-Mar 31, 2024

Enveric Biosciences's largest sold out institutional shareholder by shares sold is ARMISTICE CAPITAL, LLC, sold -0.27M shares, valued at -, as of undefined.

Enveric Biosciences Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
AdvisorShares Trust0.43%1,252,390--Dec 29, 2023
AdvisorShares Trust0.05%141,833-5,000-3.41%Dec 29, 2023
VANGUARD INDEX FUNDS0.00%36,39618,381102.03%Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%12,859--Feb 29, 2024
ADVANCED SERIES TRUST0.00%107,500--Dec 29, 2023

Enveric Biosciences's largest mutual fund holder by % of total assets is "AdvisorShares Trust", owning 1.25M shares, compromising 0.43% of its total assets.

Enveric Biosciences Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 241614.29%
31 Dec, 2314-
30 Sep, 2314-
30 Jun, 231427.27%
31 Mar, 231110.00%
31 Dec, 221025.00%
30 Sep, 228700.00%
30 Jun, 221-

As of 31 Mar 24, 16 institutions are holding Enveric Biosciences's shares, representing an increase of 14.29% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 24454,392-7.09%
31 Dec, 23489,048119.43%
30 Sep, 23222,86719.01%
30 Jun, 23187,268-13.06%
31 Mar, 23215,40224.56%
31 Dec, 22172,92517.24%
30 Sep, 22147,491-88.22%
30 Jun, 221,252,390-

Enveric Biosciences (ENVB) has 454.39K shares outstanding as of 31 Mar 24, down -7.09% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2421.05%4.12%
31 Dec, 2322.59%20.20%
30 Sep, 2310.57%13.02%
30 Jun, 239.01%8.39%
31 Mar, 2310.36%7.25%
31 Dec, 2211.96%17.56%
30 Sep, 228.25%0.06%
30 Jun, 22118.85%-

As of 31 Mar 24, Enveric Biosciences is held by 21.05% institutional shareholders, representing a 4.12% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 24775.00%
31 Dec, 234-50.00%
30 Sep, 238-
30 Jun, 23860.00%
31 Mar, 235-16.67%
31 Dec, 226-14.29%
30 Sep, 227600.00%
30 Jun, 221-

7 institutional shareholders have increased their position in ENVB stock as of 31 Mar 24 compared to 4 in the previous quarter (a 75.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 241-75.00%
31 Dec, 234300.00%
30 Sep, 231-66.67%
30 Jun, 233200.00%
31 Mar, 231-50.00%
31 Dec, 222100.00%
30 Sep, 221-
30 Jun, 22--

1 institutional shareholders have reduced their position in ENVB stock as of 31 Mar 24 compared to 4 in the previous quarter (a -75.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 241614.29%454,392-7.09%21.05%4.12%775.00%1-75.00%
31 Dec, 2314-489,048119.43%22.59%20.20%4-50.00%4300.00%
30 Sep, 2314-222,86719.01%10.57%13.02%8-1-66.67%
30 Jun, 231427.27%187,268-13.06%9.01%8.39%860.00%3200.00%
31 Mar, 231110.00%215,40224.56%10.36%7.25%5-16.67%1-50.00%
31 Dec, 221025.00%172,92517.24%11.96%17.56%6-14.29%2100.00%
30 Sep, 228700.00%147,491-88.22%8.25%0.06%7600.00%1-
30 Jun, 221-1,252,390-118.85%-1---

Enveric Biosciences Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Sep 19, 2023PASQUALONE FRANKdirector-P-PurchaseBuy1,000$2.14$2.14K1,000

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Sep 19, 2023PASQUALONE FRANKdirector-P-PurchaseBuy1,000$2.14$2.14K1,000

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Feb 26, 2024Tucker Joseph Edwarddirector, officer CHIEF EXECUTIVE OFFICERA-AwardBuy100,000--174,196
Feb 26, 2024Facchini Peter J.officer CHIEF INNOVATION OFFICERA-AwardBuy50,000--90,856
Feb 26, 2024Coveney Kevin Michaelofficer CHIEF FINANCIAL OFFICERA-AwardBuy60,000--86,500
Sep 19, 2023PASQUALONE FRANKdirector-P-PurchaseBuy1,000$2.14$2.14K1,000
Mar 14, 2023Coveney Kevin Michaelofficer Chief Financial OfficerA-AwardBuy26,500--26,500
Mar 14, 2023Coveney Kevin Michaelofficer-Buy----
Jan 27, 2023Facchini Peter J.officer Chief Innovation OfficerA-AwardBuy17,000--40,865
Jan 27, 2023Hagel Jillian Marieofficer Vice President of InnovationA-AwardBuy12,000--35,802
Jan 27, 2023Kanubaddi Avaniofficer President and COOA-AwardBuy10,000--48,346
Jan 27, 2023Tucker Joseph Edwardofficer Chief Executive OfficerA-AwardBuy44,000--74,196
Jan 25, 2023Hagel Jillian Marieofficer Chief Technology OfficerA-AwardBuy10,500--23,802
Jan 25, 2023Hagel Jillian Marieofficer Chief Technology OfficerA-AwardBuy1,021--13,302
Jan 25, 2023Facchini Peter J.officer Chief Scientific OfficerA-AwardBuy10,500--23,856
Jan 25, 2023Facchini Peter J.officer Chief Scientific OfficerA-AwardBuy1,021--13,356
Jan 25, 2023Tucker Joseph Edwardofficer Chief Executive OfficerA-AwardBuy15,000--30,196
Jan 25, 2023Tucker Joseph Edwardofficer Chief Executive OfficerA-AwardBuy1,374--15,196
Sep 23, 2022Dickey Robert IVofficer-Buy----
Jul 22, 2022PASQUALONE FRANKdirector Buy----
Jul 05, 2022O'NEIL BEVINdirector Buy----
Jun 22, 2022WEBB MICHAEL Ddirector Buy----

The last insider buy of ENVB was made by PASQUALONE FRANK on Sep 19 2023, buying 1,000 shares at $2.14 per share (worth $2.14K).

Enveric Biosciences Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 20235--
Q3 2022---
Q2 2022---
Q1 20222--
Q4 20216--
Q3 202121--
Q2 2021---
Q1 20218--
Q4 2020-1-
Q1 20191--
Q4 20181382.63%
Q3 2018144350.00%
Q2 201811100.00%
Q1 2018148175.00%
Q4 2017123400.00%
Q3 201741400.00%
Q2 2017416683.33%
Q1 20172312300.00%
Q4 20161711700.00%
Q3 201617--

5 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Enveric Biosciences's insiders, as of Q1 2023.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 2023---
Q3 2022---
Q2 2022---
Q1 2022---
Q4 2021---
Q3 2021---
Q2 2021---
Q1 2021---
Q4 2020---
Q1 2019---
Q4 2018-36-
Q3 2018-1-
Q2 201811100.00%
Q1 2018---
Q4 20178--
Q3 20172--
Q2 2017---
Q1 20175--
Q4 20168--
Q3 201616--

As of Q1 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Enveric Biosciences's stocks.

Enveric Biosciences Peer Ownership


TickerCompany
ZURAZura Bio Limited
CWBRCohBar, Inc.
ELEVElevation Oncology, Inc.
OCEAOcean Biomedical, Inc.
EFTReFFECTOR Therapeutics, Inc.
AVROAVROBIO, Inc.
HEPAHepion Pharmaceuticals, Inc.

ENVB Ownership FAQ


Enveric Biosciences is owned by institutional shareholders (21.05%), insiders (3.40%), and public (75.56%). The largest institutional shareholder of Enveric Biosciences is ADVISORSHARES INVESTMENTS LLC (11.06% of total shares) and the top mutual fund owner is AdvisorShares Trust (0.43% of total shares).

Enveric Biosciences's major institutional shareholders are ADVISORSHARES INVESTMENTS LLC, HRT FINANCIAL LP, CITADEL ADVISORS LLC, BLACKROCK INC., and SUSQUEHANNA INTERNATIONAL GROUP, LLP. The top five shareholders own together 18.05% of the company's share outstanding.

As of Mar 2024, there are 16 institutional shareholders of Enveric Biosciences.

ADVISORSHARES INVESTMENTS LLC owns 238.83K shares of Enveric Biosciences, representing 11.06% of the company's total shares outstanding, valued at $238.83K (as of Mar 2024).

As of Mar 2024, HRT FINANCIAL LP holds 63.03K shares of Enveric Biosciences (ENVB), compromising 2.92% of the company, valued at $63K.

CITADEL ADVISORS LLC is the third largest holder of Enveric Biosciences. The company owns 40.1K of the company's shares outstanding (worth $40.1K).